Kristine M. Kim BS, PhD

Kristine M. Kim is Professor of Division of Biomedical Convergence, College of Biomedical Science at Kangwon National University in Korea since 2010. Prior to her faculty position, she worked in the biopharmaceutical and biotech companies (Immunex, Amgen, and Seattle Genetics) as a scientist for the development of therapeutic antibody and antibody-drug conjugates. Her current research interests include the strategies for complementary therapeutic development to reduce both resistance and the risk of relapse, as well as concurrent identification of antibody and “novel” targets for new cancer drugs. Dr. Kim earned her Ph.D. from the University of Utah. She currently serves as department chair, council member of Korea Food and Drug Administration (KFDA), and scientific advisory board member for biotechs and many associations, including Global Bio Conference sponsored by KFDA.